Regeneron Pharmaceuticals
REGN
#244
Rank
A$143.49 B
Marketcap
A$1,387
Share price
3.74%
Change (1 day)
38.44%
Change (1 year)

Number of shares outstanding for Regeneron Pharmaceuticals (REGN)

Number of shares outstanding as of November 2026 : 101,700,000

According to Regeneron Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 101,700,000. At the end of 2024 the company had 107,800,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Regeneron Pharmaceuticals from 1996 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.10 B1.13%
20230.10 B-0.37%
20220.10 B0.75%
20210.10 B0.76%
20200.10 B-3.48%
20190.10 B0.92%
20180.10 B1.1%
20170.10 B1.82%
20160.10 B1.3%
20150.10 B2.26%
20140.10 B2.63%
201398.86 M3.31%
201295.69 M5.1%
201191.04 M4.17%
201087.4 M9.44%
200979.86 M1.18%
200878.93 M19.48%
200766.06 M15.89%
200657.01 M1.85%
200555.97 M0.92%
200455.46 M5.27%
200352.69 M19.89%
200243.95 M1.43%
200143.32 M19.91%
200036.13 M17.99%
199930.62 M-12.5%
199835 M10.53%
199731.66 M24.53%
199625.42 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Johnson & Johnson
JNJ
2,407,118,000 2,266.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
1,896,000,000 1,764.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
541,000,000 431.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,400,000,000 2,259.88%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
147,800,000 45.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
133,828,000 31.59%๐Ÿ‡บ๐Ÿ‡ธ USA